BioAge is usually a clinical-stage biotechnology enterprise producing a pipeline of solutions to increase balanced lifespan by focusing on the molecular triggers of growing older. The corporation takes advantage of its discovery platform, which mixes quantitative Assessment of proprietary longitudin